Waters Corporation’s Dave Leitham, Vice President of Informatics, says the “big win for scientists” from AI-enabled, automated lab workflows “is time”
INTERPOL Secretary General Valdecy Urquiza says the agreement with WHO is crucial to security efforts as “crime and health are increasingly interconnected”
Danaher CEO Julie Sawyer Montgomery says the company's partnership with AI giant NVIDIA will help “researchers move faster to advance discoveries”
INTERPOL Secretary General Valdecy Urquiza says the agreement with WHO is crucial to security efforts as “crime and health are increasingly interconnected”
Waters Corporation’s Dave Leitham, Vice President of Informatics, says the “big win for scientists” from AI-enabled, automated lab workflows “is time”
This week's top stories include Stryker's CEO change, Viatris' pain management deal, J&J's Q3 earnings and Flo and Google's femtech partnership
IBM’s Kaitlyn Roche and MVP Health Care’s Samantha Demick shared insights on automating healthcare vendor compliance and managing risk in a webinar
All Articles
Viatris CEO Scott Smith says the acquisition enables the firm to “strengthen our position in non-opioid pain management” and drive business growth
Electronic Health Records are evolving fast. Leaders from EY, DataArt, and Publicis Sapient explain what's driving the change – and what comes next
This week's top stories include J&J's menopause-eye health link, the UK's AI healthcare regulations, GE's HealthCare's CT technology and Bayer's Ohio site
WHO’s Director of Nutrition and Food Safety, Dr Luz María De Regill, says childhood obesity care should focus on "support" not "medicine or surgery"
Spencer Stiles, who will assume the CEO position after serving as COO at Stryker since January 2026, describes taking the role as a “tremendous privilege”
CEO Mike Mahoney names Joe Fitzgerald EVP & COO at Boston Scientific as the medtech giant restructures into three clinical segments
CEO Brian Tyler will bring McKesson’s “experience and expertise” to support Option Care Health, following a US$5.8bn joint acquisition
Danaher CEO Julie Sawyer Montgomery described the planned AI lab as “an important milestone” towards expediting “the journey from discovery to impact”
CEO Pascal Soriot says AstraZeneca’s R&D centre in Massachusetts will help the company to "discover the next generation of scientific breakthroughs"
Deputy Chair of the National Commission into the Regulation of AI in Healthcare, Henrietta Hughes, welcomed the decision to accept all 44 recommendations